Ilaria Martinelli

Ilaria Martinelli

Neurology consultant

Dr. Martinelli’s main research interests are Motor Neuron Diseases, including ALS and Spinal Bulbar Muscolar Atrophy (SBMA). She actively participated in several collaborative clinical projects, focusing on clinical follow up of patients with ALS and SBMA along with the evaluation of outcome measures and the validation of possible specific biomarkers able to improve the clinical assessment and prognosis. She took part in genetic studies and biomarkers studies in ALS, and she participated in several clinical trials in patients with ALS, SBMA and other neuromuscular disorders.

Connect
Current trials
Completed
Phase iii

ADORE trial

Industry trial

Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).

Read more
Active
Phase iii

PHOENIX trial

Industry trial

Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound ‘AMX0035’ for the treatment of ALS.

Read more
Phase i
Read more